$3.71
-0.14-3.64%
Pre-Market: 4:09 AM EDT
Comments
Loading...
bluebird bio Earnings Estimates, EPS & Revenue | NASDAQ:BLUE | Benzinga
bluebird bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-6.200
Quarterly Revenue Estimate
$25.80M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$53.12M
Analyze the earnings history of bluebird bio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BLUE | bluebird bio | — | -$3.60 | — | — | — | $37.72M | — | — | 05/08/2025 | Get Alert |
| BLUE | bluebird bio | — | -$6.20 | — | — | — | $25.80M | — | — | 04/08/2025 | Get Alert |
| BLUE | bluebird bio | -$13.20 | -$7.00 | -$6.20 | 11.43% | $12.39M | $18.68M | $10.61M | -43.19% | 11/14/2024 | Get Alert |
| BLUE | bluebird bio | -$13.40 | -$7.60 | -$8.40 | -10.53% | $6.89M | $16.88M | $16.10M | -4.61% | 09/27/2024 | Get Alert |
| BLUE | bluebird bio | $4.20 | -$8.80 | -$7.20 | 18.18% | $2.38M | $19.55M | $18.57M | -5.00% | 09/13/2024 | Get Alert |
| BLUE | bluebird bio | -$16.40 | -$13.20 | — | — | $62.00K | $16.68M | — | — | 09/13/2024 | Get Alert |
| BLUE | bluebird bio | -$18.80 | -$13.40 | -$13.20 | 1.49% | $71.00K | $13.31M | $12.39M | -6.90% | 11/07/2023 | Get Alert |
| BLUE | bluebird bio | -$27.20 | -$14.40 | -$13.40 | 6.94% | $1.52M | $9.31M | $6.89M | -25.99% | 08/08/2023 | Get Alert |
| BLUE | bluebird bio | -$33.20 | -$7.40 | $4.20 | 156.76% | $1.95M | $18.19M | $2.38M | -86.91% | 05/09/2023 | Get Alert |
| BLUE | bluebird bio | -$42.80 | -$8.80 | -$16.40 | -86.36% | $1.61M | $13.53M | $62.00K | -99.54% | 03/29/2023 | Get Alert |
| BLUE | bluebird bio | -$63.20 | -$22.40 | -$18.80 | 16.07% | $22.68M | $1.00M | $71.00K | -92.90% | 11/07/2022 | Get Alert |
| BLUE | bluebird bio | -$68.60 | -$24.80 | -$25.40 | -2.42% | $7.47M | $680.00K | $1.52M | 123.38% | 08/04/2022 | Get Alert |
| BLUE | bluebird bio | -$61.40 | -$27.80 | -$33.20 | -19.42% | $12.79M | $730.00K | $1.95M | 166.44% | 05/09/2022 | Get Alert |
| BLUE | bluebird bio | -$60.20 | -$37.60 | -$42.80 | -13.83% | $10.71M | $5.08M | $1.61M | -68.39% | 03/04/2022 | Get Alert |
| BLUE | bluebird bio | -$58.80 | -$51.60 | -$63.20 | -22.48% | $19.27M | $26.06M | $22.68M | -12.98% | 11/05/2021 | Get Alert |
| BLUE | bluebird bio | -$7.20 | -$63.80 | -$68.60 | -7.52% | $198.89M | $19.68M | $7.47M | -62.03% | 08/09/2021 | Get Alert |
| BLUE | bluebird bio | -$72.80 | -$60.20 | -$61.40 | -1.99% | $21.86M | $11.37M | $12.79M | 12.52% | 05/05/2021 | Get Alert |
| BLUE | bluebird bio | -$80.80 | -$58.40 | -$60.20 | -3.08% | $10.00M | $14.65M | $10.71M | -26.91% | 02/23/2021 | Get Alert |
| BLUE | bluebird bio | -$74.60 | -$60.20 | -$58.80 | 2.33% | $8.91M | — | $19.27M | — | 11/04/2020 | Get Alert |
| BLUE | bluebird bio | -$71.00 | -$52.00 | -$7.20 | 86.15% | $13.30M | $66.70M | $198.89M | 198.19% | 08/05/2020 | Get Alert |
| BLUE | bluebird bio | -$59.80 | -$80.20 | -$72.80 | 9.23% | $12.47M | $7.60M | $21.86M | 187.67% | 05/11/2020 | Get Alert |
bluebird bio (BLUE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-6.20 | $-7.00 | 11.4 % |
| Q2 | 2024-09-27 | $-8.40 | $-7.60 | -10.5 % |
| Q1 | 2024-09-13 | $-7.20 | $-8.80 | 18.2 % |
| Q3 | 2023-11-07 | $-13.20 | $-13.40 | 1.49 % |
bluebird bio (BLUE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $10.61M | $18.68M | -43.2 % |
| Q2 | 2024-09-27 | $16.10M | $16.88M | -4.61 % |
| Q1 | 2024-09-13 | $18.57M | $19.55M | -5.00 % |
| Q3 | 2023-11-07 | $12.39M | $13.31M | -6.90 % |
FAQ
When is bluebird bio (NASDAQ:BLUE) reporting earnings?
bluebird bio (BLUE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for bluebird bio (NASDAQ:BLUE)?
The Actual EPS was $-6.20, which beat the estimate of $-7.00.
What were bluebird bio’s (NASDAQ:BLUE) revenues?
The Actual Revenue was $10.6M, which missed the estimate of $18.7M.
Browse earnings estimates, EPS, and revenue on all stocks.